PH25025A - A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one - Google Patents
A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-oneInfo
- Publication number
- PH25025A PH25025A PH36242A PH36242A PH25025A PH 25025 A PH25025 A PH 25025A PH 36242 A PH36242 A PH 36242A PH 36242 A PH36242 A PH 36242A PH 25025 A PH25025 A PH 25025A
- Authority
- PH
- Philippines
- Prior art keywords
- methyl
- carbazol
- imidazol
- tetrahydro
- cognitive disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868630075A GB8630075D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB878726424A GB8726424D0 (en) | 1987-11-11 | 1987-11-11 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
PH25025A true PH25025A (en) | 1991-01-28 |
Family
ID=26291706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH36242A PH25025A (en) | 1986-12-17 | 1987-12-16 | A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one |
Country Status (15)
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
GB8805269D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
US5229407A (en) * | 1988-09-01 | 1993-07-20 | Glaxo Group Limited | Medicaments |
GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
AU2254692A (en) * | 1991-06-26 | 1993-01-25 | Sepracor, Inc. | Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
JPH06508836A (ja) * | 1991-06-26 | 1994-10-06 | セプラコア,インコーポレーテッド | 光学的に純粋なr(+)オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物 |
JPH08507514A (ja) * | 1993-03-08 | 1996-08-13 | 藤沢薬品工業株式会社 | 脳血管性疾患を治療または予防するための薬物 |
ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
TR200101892T2 (tr) * | 1999-01-07 | 2001-11-21 | P.N. Gerolymatos S.A. | Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı. |
CA2371822A1 (en) | 1999-03-01 | 2000-09-08 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
GB0701970D0 (en) | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI74707C (fi) * | 1982-06-29 | 1988-03-10 | Sandoz Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror. |
DE3445377A1 (de) * | 1983-12-23 | 1985-07-04 | Sandoz-Patent-GmbH, 7850 Lörrach | Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen |
IE57809B1 (en) * | 1984-01-25 | 1993-04-21 | Glaxo Group Ltd | 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives |
AU583343B2 (en) * | 1985-01-23 | 1989-04-27 | Glaxo Group Limited | Heterocyclic compounds |
US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
EP0201165B1 (en) * | 1985-03-14 | 1994-07-20 | Beecham Group Plc | Medicaments for the treatment of emesis |
US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
-
1987
- 1987-12-16 IL IL84845A patent/IL84845A0/xx not_active IP Right Cessation
- 1987-12-16 DK DK662687A patent/DK662687A/da not_active Application Discontinuation
- 1987-12-16 NZ NZ222950A patent/NZ222950A/en unknown
- 1987-12-16 JP JP62318456A patent/JP2608078B2/ja not_active Expired - Lifetime
- 1987-12-16 US US07/133,884 patent/US4845115A/en not_active Expired - Lifetime
- 1987-12-16 DE DE8787311078T patent/DE3782028T2/de not_active Expired - Lifetime
- 1987-12-16 IE IE341487A patent/IE60991B1/en not_active IP Right Cessation
- 1987-12-16 EP EP87311078A patent/EP0275668B1/en not_active Expired - Lifetime
- 1987-12-16 ES ES87311078T patent/ES2052585T3/es not_active Expired - Lifetime
- 1987-12-16 PH PH36242A patent/PH25025A/en unknown
- 1987-12-16 AU AU82614/87A patent/AU618520B2/en not_active Ceased
- 1987-12-17 KR KR1019870014391A patent/KR950013450B1/ko not_active IP Right Cessation
-
1992
- 1992-11-16 GR GR920402595T patent/GR3006255T3/el unknown
-
1993
- 1993-04-15 HK HK366/93A patent/HK36693A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169294A patent/CY1692A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2608078B2 (ja) | 1997-05-07 |
AU618520B2 (en) | 1992-01-02 |
IL84845A0 (en) | 1988-06-30 |
IE60991B1 (en) | 1994-09-07 |
KR880007074A (ko) | 1988-08-26 |
CY1692A (en) | 1994-01-14 |
ES2052585T3 (es) | 1994-07-16 |
KR950013450B1 (ko) | 1995-11-08 |
AU8261487A (en) | 1988-06-23 |
JPS63253083A (ja) | 1988-10-20 |
EP0275668A3 (en) | 1989-10-11 |
DK662687A (da) | 1988-06-18 |
NZ222950A (en) | 1997-06-24 |
HK36693A (en) | 1993-04-23 |
GR3006255T3 (US06566495-20030520-M00011.png) | 1993-06-21 |
DK662687D0 (da) | 1987-12-16 |
DE3782028T2 (de) | 1993-02-18 |
US4845115A (en) | 1989-07-04 |
EP0275668B1 (en) | 1992-09-30 |
EP0275668A2 (en) | 1988-07-27 |
IE873414L (en) | 1988-06-17 |
DE3782028D1 (de) | 1992-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2192407B (en) | Electro-coating apparatus and method | |
EP0244217A3 (en) | Process and apparatus | |
YU198087A (en) | Process for obtaining nor-statine and nor-cyclostatine | |
PH25025A (en) | A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one | |
GB2201106B (en) | Apparatus and method of securing a component | |
PL268262A1 (en) | Weedicidal specific and the method of manufacturing of new derivatives of 2-benzoylcyclohexandion-1,3 | |
RU1769757C (ru) | Cпocoб пoлучehия 1,1,1,2-tetpaфtopэtaha | |
EP0258869A3 (en) | Wire-bonding method and apparatus | |
EP0251738A3 (en) | Coating apparatus and process | |
EP0237735A3 (en) | 3,7-disubstituted-3-cephem compounds and process for production of the same | |
EP0243773A3 (en) | Method and apparatus for forming disc-wheel like formed parts | |
EP0235647A3 (en) | Process for the manufacture of 6,13-dihydroquinacridones and quinacridones | |
EP0237631A3 (en) | Method of treating photoresists | |
GB2195576B (en) | Cooling process and apparatus | |
ZA852156B (en) | A method for the treatment of glaucoma | |
GB2194416B (en) | A method of authenticating stream ciphers | |
GB2194376B (en) | Method of and device for producing multiple colors | |
HUT49858A (en) | Process for producing 5-arilidene and 5-alkilidene hydantoins | |
GB2164677B (en) | Method and apparatus for treatment of a structure | |
EP0233333A3 (en) | Method of treating photoresists | |
YU142785A (en) | Process for obtaining aromatic 1,4-oxazepinone and thione | |
PH24460A (en) | 2,3,4,10-tetrahydropyrimido(1,2-a)indoles and a method of use thereof | |
PL266142A1 (en) | Weedicidal specific and the method of manufacturing of new derivatives of 2-phenylaceto-cyclohexanotrion-1,3,5 | |
EG18303A (en) | Process and intermediate for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine | |
ZA854178B (en) | Process for producing n-acyl-hydroxy and n-acyl-acyloxy aromatic amines |